ISICEM: Albumin does not improve survival in sepsis

March 19, 2014
ISICEM: albumin does not improve survival in sepsis

(HealthDay)—For patients with severe sepsis in intensive care units, the use of albumin replacement in addition to crystalloid solution does not improve survival, according to a study published online March 18 in the New England Journal of Medicine. This research was published to coincide with the International Symposium on Intensive Care and Emergency Medicine, held from March 18 to 21 in Brussels.

Pietro Caironi, M.D., Ph.D., from the Università degli Studi di Milano, and colleagues randomized 1,818 patients with in 100 units to receive 20 percent albumin and crystalloid solution or crystalloid solution alone.

The researchers found that, compared with those in the crystalloid group, patients in the albumin group had a higher mean arterial pressure (P = 0.03) and lower net fluid balance (P < 0.001) during the first seven days. There was no significant between-group difference in the total daily amount of administered fluid (P = 0.10). At 28 days, 31.8 percent of the albumin group and 32.0 percent of the crystalloid group had died (relative risk in albumin group, 1.00; P = 0.94). Mortality at 90 days was 41.1 and 43.6 percent, respectively (relative risk, 0.94; P = 0.29).

"In with severe sepsis, albumin replacement in addition to crystalloids, as compared with crystalloids alone, did not improve the rate of survival at 28 and 90 days," the authors write.

The study was funded by the Italian Medicines Agency.

Explore further: ISICEM: Septic shock death equal with high, low BP target

More information: Abstract
Full Text
More Information

Related Stories

ISICEM: Septic shock death equal with high, low BP target

March 19, 2014
(HealthDay)—For patients with septic shock undergoing resuscitation, 28- and 90-day mortality is not significantly different with high- or low-target arterial pressure. This research was published online March 18 in the ...

Study compares risk of death of fluid replacement therapies for critically ill patients

October 9, 2013
Djillali Annane, M.D., Ph.D., of Raymond Poincare Hospital, Garches, France, and colleagues conducted a study to compare the effects of 2 types of intravenous fluids on survival for critically ill patients in an intensive ...

Albumin improves bacterial peritonitis outcomes

February 7, 2013
(HealthDay)—For patients with spontaneous bacterial peritonitis (SBP), albumin infusion is associated with reduced renal impairment and decreased mortality, according to research published in the February issue of Clinical ...

Study finds risk of death among ICU patients with severe sepsis has decreased

March 18, 2014
In critically ill patients in Australia and New Zealand with severe sepsis or septic shock, there was a decrease in the risk of death from 2000 to 2012, findings that were accompanied by changes in the patterns of discharge ...

Ringer's acetate better for patients with severe sepsis

June 28, 2012
(HealthDay) -- Fluid resuscitation with hydroxyethyl starch (HES) 130/0.4 for patients with severe sepsis leads to an increased risk of death at day 90 and an increased likelihood of requiring renal-replacement therapy, compared ...

Combination antibiotic treatment does not result in less organ failure in adults with severe sepsis

May 21, 2012
Frank M. Brunkhorst, M.D., of Friedrich-Schiller University, Jena, Germany, and colleagues conducted a study to compare the effect of the antibiotics moxifloxacin and meropenem with the effect of meropenem monotherapy on ...

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.